Skip to main content

Find Clinical Trials

Home
Conditions
Encephalitis

Clinical trial condition

Encephalitis

Explore clinical trials studying Encephalitis. Study availability and eligibility vary by location and protocol.

158 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Encephalitis trial results

Completed

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

NCT00503529

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Hospital in Debica - Zespol Opieki Zdrowotnej w Debicy Dębica, Poland

Szpital Jana Pawla II (The John Paul II Hospital) Oddzial Neuroinfekcji Krakow, Poland

View Trial Details

Completed

FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

NCT00161850

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchner Strasse 17 Wels, Austria

Neuschwanstein Strasse 5 Augsburg, Germany

Marktplatz 33 Bad Saulgau, Germany

Hauptstrasse 9 Bietigheim-Bissingen, Germany

View all 25 locations

View Trial Details

Completed

FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

NCT00161876

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Zespol Opieki Zdrowotnej w Debicy Dębica, Poland

Wojewodzki Szpital Dzieciecy Oddzial Obserwacyjno - Zakazny A Kielce, Poland

"Atopia" Diagnostyka i Leczenie Chorob Alergicznych i Ukladu Oddechowego Krakow, Poland

Przedsiebiorstwo Uslug Medycznych "Centrum Medyczne Nowa Huta" Krakow, Poland

View Trial Details

Completed

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

NCT00161889

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Neuschwanstein Strasse 5 Augsburg, Germany

Marktplatz 33 Bad Saulgau, Germany

Hauptstrasse 9 Bietigheim-Bissingen, Germany

Salzgasse 11 Calw, Germany

View all 19 locations

View Trial Details

Completed

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

NCT00161863

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchner Strasse 17 Wels, Austria

Marktplatz 3 Bad Saulgau, Germany

Solothurner Strasse 2 Heilbronn, Germany

Hauptstraße 240 Kehl, Germany

View Trial Details

Completed

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

NCT00161785

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Hospital in Debica - Zespo Opieki Zdrowotnej w Debicy Dębica, Poland

Szpital Jana Pawla II Oddzial Neuroinfekcji Krakow, Poland

View Trial Details

Completed

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

NCT00161772

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchner Strasse 17 Wels, Austria

Neuschwansteinstrasse 5 Augsburg, Germany

Marktplatz 3 Bad Saulgau, Germany

Hauptstrasse 9 Bietigheim-Bissingen, Germany

View all 23 locations

View Trial Details

Completed

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

NCT00161967

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Grieskirchner Strasse 17 Wels, Upper Austria, Austria

Hauptstrasse 240 Kehl, Germany

Niepubliczny ZOZ Zamość, Poland

View Trial Details

Completed

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

NCT00163540

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: SGS Biopharma Research Unit Stuivenberg Antwerp, Belgium

View Trial Details

Completed

Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines

NCT00735644

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +24 more
Locations: Alabang, Philippines

Bayanan, Philippines

Buli, Philippines

Cupang, Philippines

View Trial Details